Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other financing activities (2020 - 2025)

Historic Other financing activities for Palisade Bio (PALI) over the last 8 years, with Q1 2025 value amounting to $178000.0.

  • Palisade Bio's Other financing activities changed N/A to $178000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $298000.0, marking a year-over-year decrease of 4110.67%. This contributed to the annual value of $576000.0 for FY2024, which is 664.51% down from last year.
  • Palisade Bio's Other financing activities amounted to $178000.0 in Q1 2025.
  • Palisade Bio's 5-year Other financing activities high stood at $413000.0 for Q1 2023, and its period low was $15000.0 during Q3 2023.
  • Over the past 5 years, Palisade Bio's median Other financing activities value was $129500.0 (recorded in 2023), while the average stood at $173750.0.
  • Within the past 5 years, the most significant YoY rise in Palisade Bio's Other financing activities was 76875.0% (2023), while the steepest drop was 9526.81% (2023).
  • Quarter analysis of 5 years shows Palisade Bio's Other financing activities stood at $87000.0 in 2021, then surged by 237.93% to $294000.0 in 2022, then plummeted by 82.99% to $50000.0 in 2023, then surged by 140.0% to $120000.0 in 2024, then surged by 48.33% to $178000.0 in 2025.
  • Its Other financing activities was $178000.0 in Q1 2025, compared to $120000.0 in Q4 2024 and $68000.0 in Q3 2024.